Uh oh, we're in trouble. The "Mexican Blood Flu" is upon us. We've never heard of it, but it sure sounds nasty.
Rumors of a superbug virus that kills 70% of the seniors over 55 who become infected are flying around the internet via emails and a Facebook Page, which is hosted a group called Wake Up America and Stand United. Is this something you should worry about? Better read this.

On climate policy, Bernie Sanders and Alexandria Ocasio-Cortez believe there is no middle ground. AOC said, "You're either fighting for our future or you're not," which sounds an awful lot like, "You're either with us or against us." This is wrong and counterproductive.

More and more frequently, prior scientific work is not "reproducible." But is it a crisis? And does reproducibility lead us to "truth"? A study of how science may find truth discovers that the diversity of scientific approaches may be crucial.

With the hope of increasing accessibility for a burdensome medical issue, can this application actually make a dent as a screening or diagnostic tool?

Sometimes you just have to speak your mind. A TV ad demonstrates the power of language to further demean medical care.

A story that's gone viral (again) claims that McDonald's touchscreen menus are fecally tainted. Is it true? No. The global headlines saying otherwise are total lies. So, on what basis are these folks making that ridiculous claim?

Jimmy Carter is reportedly doing well, recovering from surgery for a broken hip sustained after the 94-year-old former president fell at his home. With falls among the top five leading causes of preventable death, context is paramount.

A recent paper gives us a preview of precision medicine, and the breadth of the undertaking should humble us. Consider it medicine's moonshot.

Years after his TV show, Bill Nye experienced a resurgence in popularity. But instead of the old, nerdy-but-lovable Bill Nye, we got Bill Nye 2.0, a somewhat cantankerous scold who clearly knows less about science than he leads on.

Since the focus of pharmaceutical research has shifted from oral, small molecule medications (pills) to biologics (injectables derived from living sources) the price of new drugs has soared. Biologicals are more difficult to manufacture and purify than traditional medications. Biosimilars are analogous to (but different generic versions of traditional drugs). But the difference creates a unique set of issues. ACSH friend Dr. Robert Popovian and colleagues recently wrote about some of the complexities of biosimilars.